Why Bristol Looks Like Buyout Bait

摘要

At Bristol-Myers Squibb (BMY), sales and earnings are in high gear. To some analysts, that makes it a more attractive takeover target. Buyout rumors have swirled in the past, but recently Bristol has beenrnbusy selling unprofitable assets and slashing cos